NEW YORK, NY / ACCESSWIRE / August 12, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) to a newly-formed entity ("Parent") formed on behalf of a consortium consisting of: (i) Bizuo (Tony) Liu (CEO of Cellular Biomedicine) and certain other members of Cellular Biomedicine management (Yihong Yao, Li (Helen) Zhang and Chengxiang (Chase) Dai); (ii) Dangdai International Group Co., Limited, Mission Right Limited, Wealth Map Holdings Limited, Earls Mill Limited, OPEA SRL, Maplebrook Limited, Full Moon Resources Limited, Viktor Pan and Zheng Zhou; and (iii) Yunfeng Fund III, L.P., TF Capital Fund III L.P., Velvet Investment Pte. Ltd., and Bizuo (Tony) Liu (collectively, the "Consortium").
If you are a Cellular Biomedicine shareholder and would like to discuss your legal rights and options, please visit Cellular Biomedicine Merger or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected].
Under the terms of the merger agreement, Cellular Biomedicine stockholders (excluding certain parties) will receive $19.75 in cash for each outstanding share of common stock held immediately prior to the effective time of the merger.
The investigation concerns whether Cellular Biomedicine and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders. On behalf of Cellular Biomedicine shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
If you are a Cellular Biomedicine shareholder and would like to discuss your legal rights and options, please visit https://halpersadeh.com/actions/cellular-biomedicine-group-inc-cbmg-stock-merger/ or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected].
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
CONTACT:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com
SOURCE: Halper Sadeh LLP